Jefferies cuts Syndax Pharmaceuticals target price to $17 from $35
SNDX•Jefferies cut its target price for Syndax Pharmaceuticals to $17 from $35.
Related News
Morgan Stanley is a dubious saviour for UBS
UBS•
Philips beats quarterly profit estimates on higher sales, gross margin
PHG•
SS&C flags operational challenges as retail access to private markets expands
SSNC•
Ichor Holdings cuts target price to $55 from $100
ICHR•
Jazz Pharmaceuticals PLC: JPMorgan raises target price to $310 from $300
JAZZ•